Literature DB >> 15001482

Smoking and blindness.

Simon P Kelly, Judith Thornton, Georgios Lyratzopoulos, Richard Edwards, Paul Mitchell.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15001482      PMCID: PMC381035          DOI: 10.1136/bmj.328.7439.537

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

1.  Ophthalmologists' and optometrists' attitudes and behaviours regarding tobacco cessation intervention.

Authors:  J S Gordon; J A Andrews; E Lichtenstein; H H Severson; L Akers; C Williams
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

2.  Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-04

3.  Risk factors for age-related macular degeneration: Pooled findings from three continents.

Authors:  W Smith; J Assink; R Klein; P Mitchell; C C Klaver; B E Klein; A Hofman; S Jensen; J J Wang; P T de Jong
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

Review 4.  How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

Authors:  C G Owen; A E Fletcher; M Donoghue; A R Rudnicka
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

Review 5.  The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Authors:  S Beatty; H Koh; M Phil; D Henson; M Boulton
Journal:  Surv Ophthalmol       Date:  2000 Sep-Oct       Impact factor: 6.048

6.  Smoking and age-related maculopathy. The Blue Mountains Eye Study.

Authors:  W Smith; P Mitchell; S R Leeder
Journal:  Arch Ophthalmol       Date:  1996-12

7.  Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Sandra C Tomany; Scot E Moss
Journal:  Am J Epidemiol       Date:  2002-10-01       Impact factor: 4.897

8.  Age-related macular degeneration and smoking. The Rotterdam Study.

Authors:  J R Vingerling; A Hofman; D E Grobbee; P T de Jong
Journal:  Arch Ophthalmol       Date:  1996-10

9.  The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking.

Authors:  R Klein; B E Klein; K L Linton; D L DeMets
Journal:  Am J Epidemiol       Date:  1993-01-15       Impact factor: 4.897

10.  Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study.

Authors:  Paul Mitchell; Jie Jin Wang; Wayne Smith; Stephen R Leeder
Journal:  Arch Ophthalmol       Date:  2002-10
View more
  8 in total

1.  "Sight for more eyes".

Authors:  N Astbury
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 2.  Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis.

Authors:  Elaine W-T Chong; Tien Y Wong; Andreas J Kreis; Julie A Simpson; Robyn H Guymer
Journal:  BMJ       Date:  2007-10-08

3.  Can genetic risk information for age-related macular degeneration influence motivation to stop smoking? A pilot study.

Authors:  C A Rennie; A Stinge; E A King; S Sothirachagan; C Osmond; A J Lotery
Journal:  Eye (Lond)       Date:  2011-10-28       Impact factor: 3.775

4.  28,000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking.

Authors:  J R Evans; A E Fletcher; R P L Wormald
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

5.  Chromatic Contrast Sensitivity Functions and Colour Discrimination in Smoker Patients.

Authors:  Mari Carmen García-Domene; María Josefa Luque-Cobija; Dolores de Fez; María Amparo Díez-Ajenjo
Journal:  Int J Environ Res Public Health       Date:  2022-06-07       Impact factor: 4.614

6.  Teenagers' perceptions of blindness related to smoking: a novel message to a vulnerable group.

Authors:  Phillip Moradi; Judith Thornton; Richard Edwards; Roger A Harrison; Stephen J Washington; Simon P Kelly
Journal:  Br J Ophthalmol       Date:  2007-02-06       Impact factor: 4.638

7.  Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK.

Authors:  Sobha Sivaprasad; Nachiketa Acharya; Phil Hykin
Journal:  Clin Ophthalmol       Date:  2008-06

8.  Educating smokers about the risk of blindness - insights to improve tobacco product health warning labels.

Authors:  Ryan David Kennedy; David Hammond; Marlee M Spafford; Ornell Douglas; Julie Brûlé; Geoffrey T Fong; Annette S H Schultz
Journal:  Tob Induc Dis       Date:  2016-08-19       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.